| Letters
in Drug Design & Discovery
ISSN: 1570-1808

Letters in Drug Design &
Discovery
Volume 3, Number 1, February 2006

A 3D-QSAR of N-Substituted 4-Amino3-3-Dialkyl-2
(3H)-Furanone GABAA Receptor Modulators Based
on Receptor Surface Analysis Pp. 1-8
Savita Bhutoria,
Prasenjit K. Mukherjee, Sandeep Chhabra & Nanda
Ghoshal
The present article reports a hypothetical
receptor surface model for an allosteric receptor
site, “lactone site”,
on the GABAA receptor using a set of
N-substituted 4-Amino-3, 3-dialkyl-2 (3H)-furanone
GABAA receptor modulators. |
|
|

[Back to top]
| Preliminary Investigation of Structure-Activity
Relationship of Cytotoxic Physalins Pp. 9-13 |
H.I.F. Magalhães, M.L.
Veras, O.D.L. Pessoa, E.R. Silveira, M.O. Moraes,
C. Pessoa & L.V. Costa-Lotufo
|
|

[Back to top]
| C5,C6-Disubstituted 1H-Indole-2-Carboxamides:
Synthesis and Cytotoxic Activity in the Human Non-Small
Lung Cancer Cell Line NSCLC-N16-L16 Pp. 14-16 |
Andrew Tsotinis, Maria Gerasimopoulou,
Margarita Vlachou, Dimitri Moreau & Christos
Roussakis
A series of disubstituted 1H-indole-2-carboxamides
was synthesized and evaluated in the NSCLC-N16-L16
tumor tumor cell line in vitro. One of
these analogs, 6-benzyloxy-N-[2-(1-pyrrolidinyl)ethyl]-5-methoxy-1H-indole-2-carboxamide,
showed satisfactory activity (IC50 =
13.9 µM), which merits further investigation.
|
|

[Back to top]
| Computer-Assisted Analysis of
the Interactions of Macrocyclic Inhibitors with wild Type
and Mutant D168A Hepatitis C Virus NS3 Serine Protease
Pp. 17-28 |
Elaine F.F. da Cunha, Teodorico
C. Ramalho, Carlton A.Taft & Ricardo B. de Alencastro

Molecular-mechanics-based methods have been
carried out to understand the forms of interaction
of BILN 2061 macrocyclic analogs, with wild-type
and D168A enzymes of HCV NS3 serine protease. Significant
differences between the wild type enzyme and mutant
active sites were observed such as in the case of
BILN 2061-D168A NS3 complex, the methoxy group and
nitrogen atom of the quinoline unit does not make
electrostatic contact with any residue. But, in
the case of BILN 2061-wild type NS3 complex, the
methoxy group and nitrogen atom of the quinoline
unit make significant electrostatic contact with
Arg123 and Asp168 residues. This results in enhanced
binding affinity of BILN 2061 towards the wild type
NS3 serine protease. In general, the ligand-D168A
complexes were less favorable binding free energy
(ΔG) than the ligand-wild type complexes. Based
on the binding conformations from molecular docking,
highly predictive CoMFA model were developed. These
models match well the 3D topology of the binding
site of the wild type NS3 serine protease. |
|

[Back to top]
| Enhancement of Drug Cytotoxicity
by Silicon Containing Groups Pp. 29-34 |
José M. Padrón,
Osvaldo J. Donadel, Leticia G. León, Tomás
Martín & Víctor S. Martín
The synthesis of enantiomerically pure (2R,3S)-disubstituted
tetrahydropyrans and their in vitro cytotoxicity
against a panel of six human solid tumor cell lines
is reported. The SAR study shows the relevant role
of the silyl protecting group in the enhancement
of the observed cytotoxic activity. |
|
|

[Back to top]
| Synthesis and Evaluation of Anthelmintic
and Cytotoxic Properties of bis-1,3-Azole Analogs
of Natural Products Pp. 35-43 |
D. Sellanes, L. Scarone, G.
Mahler, E. Manta, A. Baz, S. Dematteis, J. Saldaña,
L. Domínguez, P. Wipf & G. Serra
Tandem cyclizations to [2,5’] bis-1,3-azoles
provided simplified and stable models of biological
active marine natural products. The cytotoxic activity
in HCT-15 cells and the effect on the L4 larvae
of Nippostrongylus brasiliensis of the
heterocycles were evaluated. |
|

[Back to top]
| Initial Design and Synthesis of
Conformationally Restricted and Pharmacophore-Based Scaffold
Hopping Analogs of a Ras Pathway Modulator and Evaluation
of Their MAPK Inhibitory Activities Pp. 44-48 |
Sukumar Sakamuri, Quin-Zene
Chen, Yingchun Lu, Yen-Fang Keng, Vladimir Khazak,
Katrin Illgen, Silke Schabbert, Lutz Weber &
Sanjay R. Menon

Initial conformationally restricted and ligand pharmacophore-based
scaffold hopping analogs of a Ras/Raf protein interaction
inhibitor were designed and synthesized in an effort
to identify alternate chemical scaffolds inhibiting
the MAPK pathway. |
|
|

[Back to top]
| Novel 5-HT7 Ligands as Antidepressants:
Automated Synthesis of N-Substituted-N-[1-Methyl-3-(4-Methylpiperidin-1-yl)propyl]-Arylsulfonamides
Pp. 49-54 |
Eric Lattmann, Isidro Merino,
Simon Dunn, Bushra Parveen, Pornthip Lattmann, David
C. Billington, Yodchai Bunprakob & Jintana Sattayasai
Using an automated solution phase synthesis, a combinatorial
library of 384 Nsubstituted N-arylsulfonamides was
prepared with 24 chemically diverse amines 1-24
and 16 sulfonyl chlorides A-P. Sulfonamide J20,
B23, D23, G23, G23, J23, I24 and O24 displayed a
binding affinity between 100 nM and 10 nM. The crystalline
amide J20 (IC50=39 nM) and O24 (IC50=83 nM) have
shown an antidepressant activity in mice in the
despair swimming test and the tail suspension assay.
|
|

[Back to top]
| Evaluation of 2,3,4,8,13a
Hexahydro-1H-Benzo[5,6]Cyclohepta-6,7 Dihydroxy[1,2,3-ef][3]Benzazepine
Derivatives as Dopamine Receptor Ligands Pp.
55-60 |
P. Sozio, F. Pinnen, A. Cocco,
I. Cacciatore, G. Giorgioni, B. Costa, M. Montali,
G. Spoto, F. Santoleri & Antonio Di Stefano
This paper reports the synthesis of 2,3,4,8,13a-hexahydro-1H
benzo[5,6]cyclohepta-[1,2,3-ef][3]benzazepine
derivatives. 2d showed weak D1-like agonistic activity
using cGMP content assay in rat neostriatal membranes.
|
|

[Back to top]
| Pyrrolo[3,4-c]Quinoline-1,3-Diones
as Potent Caspase-3 Inhibitors: Synthesis and SAR of 8-Sulfamoyl-1,3-Dioxo-2,3-Dihydro-1H-Pyrrolo[3,4-c]Quinolines
Pp. 61-70 |
Dmitri V. Kravchenko, Julia
A. Kuzovkova, Volodymyr M. Kysil, Sergey E. Tkachenko,
Sergey Malarchuk, Ilya M. Okun & Alexandre V.
Ivachtchenko

Synthesis, biological evaluation and structure-activity
relationships
for a series of 8-sulfamide derivatives of 2,3-dihydro-1H-pyrrolo[
3,4-c]quinolines are described. These compounds
represent
a new chemotype of nonpeptide small molecule inhibitors
of
caspase-3. Among the studied compounds, several
nanomolar
inhibitors have been identified.
|
|
[Back to top]
|